
Nanomedicines for Breast Cancer Theranostics
- 1st Edition - March 8, 2020
- Imprint: Elsevier
- Editors: Nanasaheb D. Thorat, Joanna Bauer
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 2 0 0 1 6 - 2
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 2 0 0 1 7 - 9
Nanomedicines for Breast Cancer Theranostics addresses the translational aspects and clinical perspectives of breast cancer nanomedicine from a multidisciplinary perspecti… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteNanomedicines for Breast Cancer Theranostics addresses the translational aspects and clinical perspectives of breast cancer nanomedicine from a multidisciplinary perspective. The book summarizes research efforts at the preclinical and clinical stage of nanostructures and nanomedicine for dealing with the important challenge of nanomedicine translation in breast cancer theranostics. This book is an important resource for those working in both academia and industry, focusing on hot topics in biomaterials, biomedical engineering, drug delivery and oncology.
- Shows how the discovery of new nanomedicines is leading directly to an increase in the early-stage diagnosis of breast cancer
- Includes coverage of breast cancer nanomedicine standardization and characterization, highlighting newly developed treatments, diagnostics and treatment monitoring tools
- Explains why the design of nanobiomaterials make them effective drug carriers when treating breast cancer
Materials Scientists; Engineers; Oncologists; Pharmaceutical Scientists; Biomedical Researchers
- Edition: 1
- Published: March 8, 2020
- No. of pages (Paperback): 438
- No. of pages (eBook): 438
- Imprint: Elsevier
- Language: English
- Paperback ISBN: 9780128200162
- eBook ISBN: 9780128200179
NT
Nanasaheb D. Thorat
Dr. Nanasaheb Thorat is Principal Investigator funded by the Science Foundation Ireland (SFI) and Irish Research Council (IRC) Pathway Program at the University of Limerick, Ireland. He is also a Marie Curie Visiting Research Scientist at the University of Oxford, UK.
He has been deeply engaged in collaborative work with the many eminent scientists from Japan, USA, Germany, Korea, Ireland, India, Poland, Saudi Arabia and Australia. Dr. Thorat has received the European Commission’s innovation Radar “Grand Prix of the Innovation Radar Prize 2020” for developing ground-breaking technology for breast cancer theranostics.JB